0
Research
Community Pharmacists' Actions When Patients Use Complementary and Alternative Therapies with Medications
Carolyn M. Brown, PhD; Jamie C. Barner, PhD; Sonalee Shah, BPharm, MS
J Am Pharm Assoc (2003) 2005;45:41-47. doi:10.1331/1544345052843011

Abstract

Objective  To assess actions of community pharmacists in response to their patients' concurrent use of prescription medications and complementary and alternative medicine (CAM).

Design  Nonexperimental, cross-sectional mail survey.

Setting  Texas.

Participants  107 community pharmacists.

Interventions  Not applicable.

Main Outcome Measures  Pharmacists' self-reported rate of patient inquiry about CAM use and actions taken in response to CAM use.

Results  A majority (71.0%) of pharmacists had encountered patients who were using CAM, which was defined broadly in the survey to include herbal products, vitamins and minerals, homeopathic products, massage, meditation, and other types of CAM. Pharmacists documented CAM use by patients in 11.0% of cases and reported monitoring for drug-related problems in 38.4% of users. Among CAM users, pharmacists most often encouraged CAM use if medically appropriate. Pharmacists were not comfortable with responding to CAM inquiries but believed they needed adequate knowledge about CAM. In general, pharmacists rarely asked patients about their CAM use. Pharmacists' rate of inquiry about CAM use increased significantly when this information could be documented in patient profiles and when pharmacists had additional training in CAM. Also, in pharmacies that stocked herbal or homeopathic products, pharmacists were significantly more likely to encourage the use of CAM when medically appropriate and to recommend other CAM therapies appropriate for patients' conditions. When no references were available to research CAM, pharmacists tended to neither encourage nor discourage CAM use based on lack of scientific evidence of their effectiveness.

Conclusion  Most community pharmacists had patients who used CAM, but they were not proactive in inquiring about or documenting this use. They most often encouraged CAM use if deemed medically appropriate. Pharmacists' actions differed on the basis of professional and practice setting characteristics. To ensure optimal drug therapy outcomes, pharmacists should be more proactive in identifying and documenting CAM use by patients.

Sign In
APhA Members 
Welcome to JAPhA.org! Please log in below using your APhA username and password. Update your APhA profile.
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.

OR

Register for a FREE limited account to benefit from personalization features such as alerts.

References

Ni H, Simile C, Hardy AM. Utilization of complementary and alternative medicine by United States adults.  Med Care.  2002;40:353–8.[PubMed][CrossRef]
 
Druss BG, Rosenheck RA. Association between use of unconventional therapies and conventional medical services.  JAMA.  1999;282:651–6.[PubMed]
 
Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States: prevalence, costs, and patterns of use.  N Engl J Med.  1993;328:246–52.[PubMed]
 
Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990–1997.  JAMA. 1998;280:1569–75.[PubMed]
 
Egede LE, Zheng D, Ye X, Silverstein MD. The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes.  Diabetes Care.  2002;25:324–9.[PubMed]
 
Brown CM. Use of alternative therapies and their impact on patient compliance: perceptions of community pharmacists in Texas.  J Am Pharm Assoc.  1998;38:603–8.
 
Boisset M, Fitzcharles M. Alternative medicine use by rheumatology patients in a universal health care setting.  J Rheumatol.  1994;21:148–52.[PubMed]
 
Bennett G, Brown CM. Use of herbal remedies by patients in a health maintenance organization.  J Am Pharm Assoc.  2000;40:353–8.
 
Brown CM, Segal R. The effects of health and treatment perceptions on the use of prescribed medication and home remedies among African American and white American hypertensives.  Soc Sci Med.  1996;43:903–17.[PubMed]
 
Kim M, Han H, Kim K, Duong DN. The use of traditional and Western medicine among Korean American elderly.  J Comm Health.  2002;27:109–20.
 
O'Donnell DC, Brown CM, Piziak VK. Use of alternative therapies and compliance with prescribed regimens among patients attending a multidisciplinary lipid clinic.  Am J Heath Syst Pharm.  2001;58:1017–21.
 
Mäntyranta T, Hemminki E, Koskela K. Use of alternative drugs in Finland.  Pharmacoepidemiol Drug Saf.  1999;8:23–9.[PubMed]
 
Astin JA. Why patients use alternative medicine: results of a national study.  JAMA.  1998;279:1548–53.[PubMed]
 
Sleath B, Rubin RH, Campbell W, et al. Ethnicity and physician–older patient communication about alternative therapies.  J Altern Complement Med.  2001;7:329–35.[PubMed]
 
Eliason BC, Kruger J, Mark D, et al. Dietary supplement users: demographics, product use, and medical system interaction.  J Am Board Fam Pract.  1997;10:265–71.[PubMed]
 
Bouldin AS, Smith MC, Garner DD, et al. Pharmacy and herbal medicine in the U.S.  Soc Sci Med.  1999;49:279–89.[PubMed]
 
Miller MJ, Ortmeir BG. Factors influencing the delivery of pharmacy services.  Am Pharm.  1995;NS35(1):39–45.
 
Christensen DM, Hansen RW. Characteristics of pharmacies and pharmacists associated with the provision of cognitive services in the community setting.  J Am Pharm Assoc.  1999;39:640–9.
 
Raisch DW. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings.  Ann Pharmacother.  1993;27:1173–9.[PubMed]
 
Schommer JC, Weiderholt JB. A field investigation of participant and environment effects on pharmacist–patient communication in community pharmacies.  Med Care.  1995;33:567–84.[PubMed]
 
Astin JA, Shapiro SK, Eisenberg DM, Forys KL. Mind-body medicine: state of the science, implications for practice.  J Am Board Fam Pract.  2003;16:131–47.[PubMed]
 
Shapiro D, Hui KK, Oakley ME, et al. Reduction in drug requirements for hypertension by means of a cognitive-behavioral intervention.  Am J Hypertens.  1997;10:9–17.[PubMed]
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
PubMed Articles
Advertisement
 
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints